Regulation and metabolism of arachidonic acid

Clinical Reviews in Allergy and Immunology

Volumn 17, Issue 1-2, 1999, Pages 5-26

  Seeds, Michael C ^a   Bass, David A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AMINO ACID; ARACHIDONIC ACID; CYTOCHROME P450; ICOSANOID; LIPOXYGENASE; LYSOPHOSPHOLIPID; PHOSPHOLIPASE A2; PROSTAGLANDIN SYNTHASE;

ARACHIDONIC ACID METABOLISM; ARTICLE; CELL METABOLISM; CHEMICAL REACTION; DIETARY INTAKE; ENZYME ACTIVITY; ENZYME RELEASE; MEDIATOR RELEASE; MOLECULAR DYNAMICS; REACTION ANALYSIS; REGULATORY MECHANISM; SYNTHESIS;

EID: 0032796071     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02737594     Document Type: Article

References (114)

1. Murphy RC. in: Nigam P, Kunkel G, Prescott S, Vargaftig B, eds, Platelet-Activating Factor and Related Lipid Mediators in Health and Disease. New York: Plenum, 1997; pp. 51-58.
2. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway - Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990;323:645-655.
3. Chang S-W, Voelkel NF: Inflammatory mediator effects on pulmonary blood flow, edema, and the vascular endothelium. In: Bray MA, Anderson WH, eds, Lung Biology in Health and Disease, Vol. 54.1991; pp. 403-453.
4. Lemanske RF. Mechanisms of airway inflammation. Chest 1992;101:372S-7S.
5. Wenzel SE. Arachidonic acid metabolites: Mediators of inflammation in asthma. Pharmacotherapy 1997;17:4S-12S.
6. Chilton FH, Fonteh AN, Surette ME, Triggiani M, Winkler JD. Control of arachidonate levels within inflammatory cells. Bioch Biophys Acta 1996;1299:1-15.
7. Habenicht AJR, Salbach P, Goerig M, Zeh W, Janssen-Timen U, Blattner C, King WC, Glomset JA. The LDI, receptor pathway delivers arachidonic acid for eicosanoid formation in cells stimulated by platelet-derived growth factor [published erratum appears in Nature 1990;346:589]. Nature 1990;345:634-636.
8. Chilton FH, Averill FJ, Hubbard WC, Fonteh AN, Triggiani M, Lui MC. Antigen-induced generation of lyso phospholipids in human airways. J Exp Med 1996;183:2235-2245.
9. Balsinde J, Dennis EA. Function and inhibition of intracellular calcium independent phospholipase A2. J Biol Chem 1997;272:16,069-16,072.
10. Chilton FH, Connell TR. 1-Ether-linked phosphoglycerides. Major endogenous sources of arachidonate in the human neutrophil. J Biol Chem 1988;263:5260-5265.
11. Tessner TG, Greene DG, Wykle RL. Selective deacylation of arachidonate-containing ethanolamine-linked phosphoglycerides in stimulated human neutrophils. J Biol Chem 1990;265:21,032-21,038.
12. Winkler JD, Sung CM, Huang L, Chilton FH. CoA-independent transacylase activity is increased in human neutrophils after treatment with tumor necrosis factor alpha. Biochim Biophys Acta 1994;1215:133-140.
13. Seeds MC, Chilton FH, Bowton DL, Goldsmith B, Bass DA. Antigen challenge activates CoA-independent transacylase in peripheral blood eosinophils of asthmatic patients. Am J Respir Crit Care Med 1997;155:A58.
14. Kelly PT, Chilton FH, Seeds MC, Chin R, Bass DA. CoA-independent transacylase activity is increased in lung cancer. Am J Respir Crit Care Med 1997;155:A40.
15. Kelly PT, Chin R, Seeds MC, et al. Enhanced expression of cytosolic phospholipase A2 in bronchogenic carcinoma. Am J Respir Crit Care Med 1995;151:(4)212.
16. Kunkel SL, Ogawa H, Ward PA, Zurier RB. Suppression of chronic inflammation by evening primrose. Prog Lipid Res 1997;20:885-888.
17. Chilton-Lopez T, Surette ME, Swan DD, Fonteh AN, Johnson MM, Chilton FH. Metabolism of gammalinolenic acid in human neutrophils. J Immunol 1996;156:2941-2947.
18. Johnson MM, Swan DD, Surette ME, Stegner J, Chilton T, Fonteh AN, Chilton FH. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eixosanoid production in healthy humans. J Nutri 1997;127:1435-1444.
19. Prescott SM. The effect of eicosapentaenoic acid on leukotrine B production by human neutrophils. J Biol Chem 1984;259:7615-7621.
20. Chilton FH, Murphy RC. Remodeling of arachidonate-containing phosphoglycerides within the human neutrophil. J Biol Chem 1986;261:7771-7777.
21. Waite BM. Handbook of Lipid Research, vol. 5: The Phospholipases (Hanahan D, ed.), Plenum, New York, 1987.
22. Triggiani M, Schleimer RP, Tomioka K, Hubbard WC, Chilton FH. Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colonystimulating factor-primed human eosinophils. Immunology 1992;77:500-504.
23. Kroegel C, Liu MC, Hubbard WC, Lichtenstein LM, Bochner BS. Respiratory pathophysiologic responses. Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: Surface phenotype, density heterogeneity, and prostanoid production. J Allergy Clin Immunol 1994;93:725-734.
24. Horvath CJ, Kaplan JE, Malik AB. Role of platelet-activating factor in mediating tumor necrosis factor alpha-induced pulmonary vasoconstriction and plasma-lymph protein transport. Am Rev Respir Dis 1991;144:1337-1341.
25. Henson PM, Barnes PJ, Banks-Schlegel SP. Platelet-activating factor: Role in pulmonary injury and dysfunction and blood abnormalities. Am Rev Respir Dis 1992;145:726-731.
26. Alonso F, Henson PM, Leslie CC. A cytosolic phospholipase in human neutrophils that hydrolyzes arachidonoyl-containing phosphatidylcholine. Bioch Biophys Acta 1986;878:273-280.
27. Sharp JD, White DL, Chiou XG, Goodson T, Gamboa GC, McClure D, Burgett S, Hoskins J, Skatrud PL, Sportsman JR, et al. Molecular cloning and expression of human Ca2+-sensitive cytosolic phospholipase A2. J Biol Chem 1991;266:14,850-14,853.
28. Lin LL, Lin AY, Knopf J. Cytosolic phospholipase A2 is coupled to hormonally regulated release of arachidonic acid. Proc Natl Acad Sci USA 1992;89:6147-6151.
29. Seeds MC, Jones DF, Chilton FH, Bass DA. Secretory and cytosolic phospholipases A2 are activated during TNF priming of human neutrophils. Bioch Biophys Acta 1998;in press.
30. Kramer RM, Roberts EF, Manetta J, Putnam JE. The Ca2+-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells. J Biol Chem 1991;266:5268-5272.
31. 2+-dependent translocation domain with homology to PKC and GAP. Cell 1991;65:1043-1051.
32. Channon JY, Leslie CC. A calcium-dependent mechanism for associating a soluble arachidonoyl-hydrolyzing phospholipase A2 with membrane in the macrophage cell line RAW 264.7. J Biol Chem 1990;265:5409-5413.
33. Ramesha CS, Ives DL. Detection of an arachidonoyl-selective phospholipase A2 in human neutrophil cytosol. Biochim Biophys Acta Lipids Lipid Metab 1993;1168:37-44.
34. Seeds MC, Burke HL, Bowton DL, Bass DA. cPLA2 is primed in peripheral blood eosinophils of asthmatics before and after antigen challenge. Am J Respir Crit Care Med 1996;153:A58.
35. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell 1993;72:269-278.
36. Kramer RM, Roberts EF, Hyslop PA, Utterback BG, Hui KY, Jakubowski JA. Differential activation of cytosolic phospholipse A2 by thrombin and thrombin receptor antagonist peptide in human platelets. J Biol Chem 1995;270:14,816-14,823.
37. Fouda SI, Molski TFP, Ashour MS, Sha'afi RI. Effect of lipopolysaccharide on mitogenactivated protein kineses and cytosolic phospholipase A2. Biochem J 1995;308:815-822.
38. de Carvalho MGS, McCormack AL, Olson E, Ghomashchi F, Gelb MH, Yates JR, 111, Leslie CC. Identification of phosphorylation sites of human 85-kDa cytosolic phospholipase A2 expressed in insect cells and present in human monocytes. J Biol Chem 1996;271:6987-6997.
39. Leslie CC. Properties and Regulation of Cytosolic Phospholipase A2. J Biol Chem 1997;272:16,709-16,712.
40. Nalefski EA, Sultzman LA, Martin DM, Kriz RW, Towler PS, Knopf J L, Clark J D. Delineation of two functionally distinct domains of cytosolic phospholipase A2, a regulatory Ca(2+)dependent lipid-binding domain and a Ca(2+)-independent catalytic domain. J Biol Chem 1994;269:18,239-18,249.
41. Clark JD, Schievella AR, Nalefski EA, Lin L-L. Cytosolic phospholipase A2. J Lipid Mediat Cell Signal 1997;12:83-117.
42. Glover S, Bayburt T, Jonas M, Chi E, Gelb MH. Translocation of the 85-kDa phospholipase A2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen. J Biol Chem 1995;270:15,359-15,367.
43. Peters-Golden M, McNish RW. Redistribution of 5-lipoxygenase and cytosolic phospholipase A2 to the nuclear fraction upon macrophage activation. Bioch Biophys Res Commun 1993;196:147-153.
44. Woods JW, Coffey MJ, Brock TG, Singer II, Peters-Golden M. 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J Clin Invest 1995;95:2035-2046.
45. Brock TG, Paine R, III, Peters-Golden M. Localization of 5-lipoxygenase to the nucleus of unstimulated rat basophilic leukemia cells. J Biol Chem 1994;269:22,059-22,066.
46. Lin LL, Lin AY, DeWitt DL. Interleukin-1 alpha induces the accumulation of cytosolic phospholipase A2 and the release of prostaglandin E2 in human fibroblasts. J Biol Chem 1992;267:23,451-23,454.
47. Pete MJ, Exton JH. Purification of a lysophospholipase from bovine brain that selectively deacylates arachidonoyl-substituted lysophosphatidylcholine. J Biol Chem 1996;271:18,114-18,121.
48. Wu T, Levine SJ, Lawrence MG, Logun C, Angus CW, Shelhamer JH. Interferon-gamma induces the synthesis and activation of cytosolic phospholipase A2. J Clin Invest 1994;93:571-577.
49. Fonteh AN, Samet JM, Chilton FH. Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factor. J Clin Invest 1995;96:1432-1439.
50. Lin L-L, Lin AY, DeWitt DL. Interleukin-1a induces the accumulation of cytosolic phospholipase A2 and the release of prostaglandin E2 in human fibroblasts. J Biol Chem 1992;267:23,451-23,454.
51. Doerfler ME, Weiss J, Clark JD, Elsbach P. Bacterial lipopolysaccharide primes human neutrophils for enhanced release of arachidonic acid and causes phosphorylation of an 85 kD cytosolic phospholipase A2. J Clin Invest 1994;93:1583-1591.
52. Rodewald E, Tibes U, Maess G, Scheuer W. Induction of cytosolic phospholipase A2 in human leukocytes by lipopolysaccharide. Eur J Biochem 1994;223:743-749.
53. Durstin M, Durstin S, Molski TFP, Becker EL, Sha'afi RI. Cytoplasmic phospholipase A2 translocates to membrane fraction in human neutrophils activated by stimuli that phosphorylate mitogen-activated protein kinase. Proc Natl Acad Sci USA 1994;91:3142-3146.
54. Nixon AB, Seeds MC, Bass DA, Smitherman PK, O'Flaherty JT, Daniel LW, Wykle RL. Comparison of alkylacylglycerol vs. diacylglycerol as activators of mitogen-activated protein kinase and cytosolic phospholipase A2 in human neutrophil priming. Bioch Biophys Acta 1997;1347:219-230.
55. Miyashita A, Crystal RG, Hay JG. Identification of a 27 bp 5′-flanking region element responsible for the low level constitutive expression of the human cytosolic phospholipase A2 gene. Nucleic Acids Res 1995;23:293-301.
56. Sharp JD, White DL. Cytosolic PLA2: mRNA levels and potential for transcriptional regulation. J Lipid Mediators 1993;8:183-189.
57. Tay A, Squire JA, Goldberg H, Skorecki K. Assignment of the human prostaglandinendoperoxide synthase 2 (PTGS2) gene to 1 q25 by fluorescence in situ hybridization. Genomics 1994;26:718,719.
58. Murphy KR, Wilson MC, Irvin CG, Glezen LS, Marsh WR, Haslett C, Henson PM, Larsen GL. The requirement for polymorphonuclear leukocytes in the late asthmatic response and heightened airways reactivity in an animal model. Am Rev Respir Dis 1986;134:62-88.
59. Minna JD. The molecular biology of lung cancer pathogenesis. Chest 1993;103:449S-456S.
60. Weiss J, Franson RC, Beckerdite S, Schmeidler K, Elsbach P. Partial characterization and purification of a rabbit granulocyte factor that increases permeability of Escherichia coli. J Clin Invest 1975;55:33-42.
61. Offenstadt G, Pinta P, Masliah J, Alcindor LG, Hericord P, Amstutz P. Phospholipasic and prophospholipasic activities in bronchoalveolar ravage fluid in severe acute pulmonary disease with or without ARDS. Intensive Care Med 1981;7:285-290.
62. Seilhamer JJ, Randall TL, Yamanaka M, Johnson LK. Pancreatitc phospholipae A2: Isolation of the human gene and cDNAs from porcine pancreas and human lung. DNA 1986;5:519-527.
63. Dennis EA. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem 1994;269:13,057-13,060.
64. Tischfield JA. A reassessment of the low molecular weight phospholipase A2 gene family in mammals. J Biol Chem 1997;272:17,247-17,250.
65. Cuppillard L, Koumanov K, Mattei M-G, Lazdunski M, Lambeau G. Cloning, chromosomal mapping, and expression of a novel human secretory phospholipase A2. J Biol Chem 1997;272:15,745-15,752.
66. Murakami M, Kudo I, Inoue K. Eicosanoid generation from antigen-primed mast cells by extracellular mammalian 14-kDa group II phospholipase A2. FEBS Lett 1991;294:247-251.
67. Fonteh AN, Bass DA, Marshall LA, Seeds MC, Samet JM, Chilton FH. Evidence that secretory phospholipase A2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells. J Immunol 1994;152:5438-5446.
68. Hara S, Kudo I, Inoue K. Augmentation of prostaglandin E2 production by mammalian phospholipase A2 added exogenously. J Biochem 110:163-165.
69. Bowton DL, Seeds MC, Fasano MB, Goldsmith B, Bass DA. Phospholipase A2 and arachidonic acid are increased in bronchoalveolar ravage fluid after inhaled antigen challenge in asthmatics. Am J Respir Crit Care Med 1997;155:421-425.
70. Lambeau G, Ancian P, Barhanin J, Lazdunski M. Cloning and expression of a membrane receptor for secretory phopsholipases A2. J Biol Chem 1994;269:1575-1578.
71. Kishino J, Kawamoto K, Ishizaki J, Verheij HM, Ohara O, Arita H. Pancreatic-type phospholipase A2 activates prostaglandin E2 production in rat mesangial cells by receptor binding reaction. J Biochem 1995;117:420-424.
72. Murakami M, Kudo I, Inoue K. Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type phospholipases A2. J Biol Chem 1993;268:839-844.
73. Weiss J, Inada M, Elsbach P, Crowl RM. Structural determinants of the action against Escherichia coil of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes. J Biol Chem 1994;269:26,331-26,337.
74. Hada S, Fujii S, Inoue S, Ikeda K, Teshima K. Hydrolysis of micellar diheptanoylphosphatidylcholine catalyzed by bovine pancreatic phospholipase A2: Kinetic characterization of group I and II enzymes. J Biochem (Tokyo) 1993;113:13-18.
75. Kato T, Lee S, Oishi O, Aoyagi H, Ohno M. Interactions of N-terminal fragments of groups I and II phospholipases A2 with phospholipid bilayers and their surface recognition properties. Bioch Biophys Acta 1994;1211:215-220.
76. Gronroos JM, Kuttila K, Nevalainen TJ. Group II phospholipase A2 in serum in critically ill surgical patients. Crit Care Med 1994;22.
77. Rae D, Porter J, Beechey-Newman N, Sumar N, Bennett D, Hermon-Taylor, J. Type I prophospholipase A2 propeptide in acute lung injury. Lancet 1994;344:1472,1473.
78. Seilhamer J J, Pruzanski W, Vadas P, Plant S, Miller JA, Kloss J, Johnson LK. Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid. J Biol Chem 1989;264:5335-5338.
79. Kramer RM, Hession C, Johansen B, Hayes G, McGray P, Chow EP, Tizard R, Pepinsky RB, Structure and properties of a human non-pancreatic phospholipase A2. J Biol Chem 1989;264:5768-5775.
80. Rosenthal MD, Gordon MN, Buescher ES, Slusser JH, Harris LK, Franson, RC. Human neutrophils store type I114-kDa phospholipase A2 in granules and secrete active enzyme in response to soluble stimuli. Biochem Biophys Res Commun 1995;208:650-656.
81. Murakami M, Kobayashi T, Umeda M, Kudo I, Inoue K. Monoclonal antibodies against rat platelet phospholipase A2. J Biochem 1988;104:884-888.
82. Kim DK, Fukuda T, Thompson BT, Cockrill B, Hales C, Bonventre JV. Bronchoalveolar ravage fluid phospholipase A2 activities are increased in human adult respiratory distress syndrome. Am J Physiol 1995;269:L109-118.
83. Wright GW, Ooi CE, Weiss J, Elsbach P. Purification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudate. J Biol Chem 1990;265:6675-6681.
84. Weinrauch Y, Elsbach P, Madsen LM, Foreman A, Weiss J. The potent anti Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J Clin Invest 1996;97:250-257.
85. Chen J, Engte SJ, Seilhamer JJ, Tischfield JA. Cloning and characterization of novel rat and mouse low molecular weight Ca2+-dependent phospholipase A2s containing 16 cysteines. J Biol Chem 1994;269:23,018-23,024.
86. Chen J, Engle SJ, Seihamer JJ, Tischfield JA. Cloning and recombinant expressin of a novel human low molecular weight Ca2-dependent phospholipase A2. J Biol Chem 1994;269:2365-2368.
87. Balboa MA, Balsinde J, Winstead MV, Tischfield JA, Dennis EA. Novel group V phospholipase A2 involved in arachidonic acid mobilization in murine P388D1 macrophages. J Biol Chem 1996;271:32,381-32,384.
88. Reddy ST, Winstead MV, Tischfield JA, Herschman HR. Analysis of the secretory phospholipase A2 that mediates prostaglandin production in mast cells. J Biol Chem 1997;272:13,591-13,596.
89. Seeds MC, Bass DA. RT-PCR identification of four isotypes of secretory phospholipase A2 in adult human lung. Am J Respir Crit Care Med 1998;in press.
90. Hite RD, Seeds MC, Bala N, Waite BM, Bass DA. The secretory phospholipase of human synovial fluid does not inhibit the function of porcine surfactant. J Invest Med 1996;44:257A.
91. Ely EW, Seeds MC, Jones DF, Chilton FH, Bass DA. Neutrophil release of arachidonic acid, oxidants and proteinases: Causally related or independent? Bioch Biophys Acta 1995;1258:13,544.
92. Ancian P, Lambeau G, Mattei M-G, Lazdunski M. The human 180-kDa receptor for secretory phospholipase A2. Molecular cloning identification of a secreted soluble form, expression, and chromosomal localization. J Biol Chem 1995;270:8963-8970.
93. Kim DK, Fukuda T, Thompson BT, Cockrill b, Hales C, Bonventre JV. Bronchoalveolar ravage fluid phospholipase A2 activities are increased in human adult respiratory distress syndrome. Am J Physiol 1995;269:L109-118.
94. Bolognese B, McCord M, Marshall LA. Differential regulation of elicited-peritoneal macrophage 14 kDa and 85 kDa phospholipase A2(s) by transforming growth factor-Beta. Bioch Biophys Acta 1995;1256:201-209.
95. Hidi R, Katchourine I, Vargaftig BB, Touqui L. Selective synthesis of a secretory phospholipase A2 during adherence of guinea-pig alveolar macrophages. Agents & Actions 1994;41:C153,154.
96. Crowl RM, Stoller TJ, Conroy RR, Stoner CR. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 1991;266:2647-2651.
97. Andersen S, Bjermer L, Selbo PK, Dalaker M, Johansen B. Extracellular phospholipase A2 expression in sarcoidosis. Sarcoidosis, Vasculitis and Diffuse Lung Diseases 1997;13:70-76.
98. Aribe L, Vial D, Rosinski-Chupin I, Havet N, Huerre M, Vargaftig BB, Touqui L. Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: Involvement of TNF-alfa in lipopolysaccharide-induced type II phospholipase synthesis. J Immunol 1997;159:391-400.
99. Nevalainen TJ, Kallejoki M, Pesonen E, Andersson S, Karkkainen P, Hockerstedt K. Origin of circulating group II phospholipase A2 in hepatocytes in a patient with epitheloid hemangioendothelioma of the liver. Lab Invest 1997;74:585-591.
100. Nevalainen TJ, Gronroos JM, Kallajoki M. Expression of group 11 phospholipase A2 in the human gastrointestinal tract. Lab Invest 1997;72:201-208.
101. Ackermann EJ, Kempner ES, Dennis EA. Ca(2+)-independent cytosolic phospholipase A2 from macrophage-like P388D1 cells. Isolation and characterization. J Biol Chem 1994;269:722-733.
102. Tang J, Kriz RW, Wolfman N, Schaffer M, Seehra J, Jones SS. A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs. J Biol Chem 1997;272:8567-8575.
103. 2+-independent phospholipase A2 enzymes from P388D1 macrophages and Chinese hamster ovary cells. J Biol Chem 1997;272:8576-8580.
104. Ackermann EJ, Dennis EA. Mammalian calcium-independent phospholipase A2. Bioch Biophys Acta 1995;1259:125-136.
105. Hattori M, Adachi H, Tsujimoto M, Arai H, Inoue K. The catalytic subunit of bovine brain platelet-activating factor acetylhydrolase is a novel type of serine esterase. J Biol Chem 1995;269:23,150-23,155.
106. Herschman HR. Prostaglandin synthase 2. Bioch Biophys Acta 1996;1299:125-140.
107. DeWitt DL. Prostaeglandin endoperoxide synthase: Regulation of enzyme expression. Bioch Biophys Acta 1991;1083:121-134.
108. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Dubois RN. Upregulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;7107:1183-1188.
109. Crofford LJ, Wilder RL, Ristinaki AP, Sano H, Remmers EF, Epps HR, Hla T. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin1,B, phorbol ester, and corticosteroids. J Clin Invest 1994;93:1095-1101.
110. Murakami M, Matsumoto R, Austen KF, Arm JP. Prostaglandin endoperoxide synthase-1 and -2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells. J Biol Chem 1994;269:22,269-22,275.
111. Kawata R, Reddy ST, Wolner B, Herschman HR. Prostaglandin synthase I and prostaglandin synthase 2 both participate in activation-induced prostaglandin D2 production in mast cells. J Immunol 1995;155:818-825.
112. Morita I, Schindler M, Regier MK, Otto JC, Hori T, DeWitt DL, Smith WI. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 1995;270:10,902-10,908.
113. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 1987;237:1171-1176.
114. Rahman M, Wright, Jr., Douglas JG. The role of the cytochrome P450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function. Am J Hypertens 1997;10:356-365.